After a rare view inside the world of professional sports and orthopedic medicine through a clinical rotation with the Houston Texans this summer, Analisa Narro, a fourth-year student with McGovern Medical School at UTHealth Houston, brought back key lessons from the enriching experience.
Clinical Challenges: Beyond CDK4/6 Inhibition in Advanced HR-Positive Breast Cancer
The emergence of CDK4/6 inhibitors has reshaped the therapeutic landscape for advanced hormone receptor (HR)-positive breast cancer, extending progression-free survival (PFS) and in some cases